INTRODUCTION: The conditional nebulin knockout mouse is a new model mimicking nemaline myopathy, a rare disease characterized by muscle weakness and rods within muscle fibers. We investigated the impact of nebulin (NEB) deficiency on muscle function in vivo. METHODS: Conditional nebulin knockout mice and control littermates were studied at 10 to 12 months. Muscle function (force and fatigue) and anatomy (muscles volume and fat content) were measured in vivo. Myosin heavy chain (MHC) composition and nebulin (NEB) protein expression were assessed by protein electrophoresis. RESULTS: Conditional nebulin knockout mice displayed a lower NEB level (-90%) leading to a 40% and 45% reduction in specific maximal force production and muscles volume, respectively. Nebulin deficiency was also associated with higher resistance to fatigue and increased MHC I content. DISCUSSION: Adult nebulin-deficient mice displayed severe muscle atrophy and weakness in vivo related to a low NEB content but an improved fatigue resistance due to a slower contractile phenotype.
INTRODUCTION: The conditional nebulin knockout mouse is a new model mimicking nemaline myopathy, a rare disease characterized by muscle weakness and rods within muscle fibers. We investigated the impact of nebulin (NEB) deficiency on muscle function in vivo. METHODS: Conditional nebulin knockout mice and control littermates were studied at 10 to 12 months. Muscle function (force and fatigue) and anatomy (muscles volume and fat content) were measured in vivo. Myosin heavy chain (MHC) composition and nebulin (NEB) protein expression were assessed by protein electrophoresis. RESULTS: Conditional nebulin knockout mice displayed a lower NEB level (-90%) leading to a 40% and 45% reduction in specific maximal force production and muscles volume, respectively. Nebulin deficiency was also associated with higher resistance to fatigue and increased MHC I content. DISCUSSION: Adult nebulin-deficient mice displayed severe muscle atrophy and weakness in vivo related to a low NEB content but an improved fatigue resistance due to a slower contractile phenotype.
Authors: Mai-Anh T Nguyen; Josephine E Joya; Anthony J Kee; Ana Domazetovska; Nan Yang; Jeff W Hook; Frances A Lemckert; Emma Kettle; Valentina A Valova; Philip J Robinson; Kathryn N North; Peter W Gunning; Christina A Mitchell; Edna C Hardeman Journal: Brain Date: 2011-11-08 Impact factor: 13.501
Authors: Marie-Louise Bang; Xiaodong Li; Ryan Littlefield; Shannon Bremner; Andrea Thor; Kirk U Knowlton; Richard L Lieber; Ju Chen Journal: J Cell Biol Date: 2006-06-12 Impact factor: 10.539
Authors: Coen A C Ottenheijm; Danielle Buck; Josine M de Winter; Claudia Ferrara; Nicoletta Piroddi; Chiara Tesi; Jeffrey R Jasper; Fady I Malik; Hui Meng; Ger J M Stienen; Alan H Beggs; Siegfried Labeit; Corrado Poggesi; Michael W Lawlor; Henk Granzier Journal: Brain Date: 2013-05-28 Impact factor: 13.501
Authors: Coen A C Ottenheijm; Pleuni Hooijman; Elizabeth T DeChene; Ger J Stienen; Alan H Beggs; Henk Granzier Journal: J Struct Biol Date: 2009-11-26 Impact factor: 2.867
Authors: Coen A C Ottenheijm; Christian C Witt; Ger J Stienen; Siegfried Labeit; Alan H Beggs; Henk Granzier Journal: Hum Mol Genet Date: 2009-04-04 Impact factor: 6.150